Word: fivefold
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...heavy herbe smokers who developed ischemia (an insufficient blood supply) in their limbs, leading in four cases to amputations. It's not clear that marijuana caused the decreased blood flow, but the vascular problems did worsen during periods of heavy use. Another 2001 paper, in Circulation, found a nearly fivefold increase in the risk for heart attack in the first hour after smoking marijuana--though statistically that means smoking pot is about as dangerous for a fit person as exercise...
...Gonzalo Sanchez, a former President. More than that, Evo-speak--"The drug war is just a U.S. excuse to control our countries"--resonates beyond Bolivia's borders. Next door in Peru, irate coca farmers have successfully pressured the government to suspend eradication. In Colombia, the coca crop has grown fivefold in five years, to more than 400,000 acres, despite almost $1 billion in U.S. eradication funds. Authorities now say they will spray only "industrial-size" coca fields and not those of smaller farmers, who are, of course, the voters. If Morales can thwart the U.S. in Bolivia--South America...
...SMALLPOX When a smallpox attack looked like a real possibility last fall, smallpox vaccines were in desperately short supply. Or were they? U.S. officials announced last week that the 15.4 million freeze-dried doses left over from the early '70s can be diluted fivefold--stretching the stockpile to more than 75 million--and still remain potent. Meanwhile, a French drug company offered up a forgotten cache of 85 million more doses. That should tide us over until year's end, when new vaccines...
...while IBM is indeed in solid shape, its earnings have grown 20 percent annually since 1994 while its revenues have grown only 5 percent a year over the same time period. Should the stock really be up more than fivefold...
...Heidelberg, Germany; Gene Logic of Gaithersburg, Md.; and Compugen of Princeton, N.J., have been selling their expertise in bioinformatics to big drug companies. But they face heavyweight competition from the likes of Hitachi and IBM, hungry for a slice of a bioinformatics market that Frost & Sullivan predicts will grow fivefold, to $7 billion over the next five years...